相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages
Giulia Abate et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches
Chun-Hung Chang et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Application and assessment of deep learning for the generation of potential NMDA receptor antagonists
Katherine J. Schultz et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2021)
Application of modern neuroimaging technology in the diagnosis and study of Alzheimer's disease
Hong-Mei Zeng et al.
NEURAL REGENERATION RESEARCH (2021)
Glutamatergic response to a low load working memory paradigm in the left dorsolateral prefrontal cortex in patients with mild cognitive impairment: a functional magnetic resonance spectroscopy study
Anupa A. Vijayakumari et al.
BRAIN IMAGING AND BEHAVIOR (2020)
Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches
Eugene Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study
Dickson Wong et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Development and validation of an interpretable deep learning framework for Alzheimer's disease classification
Shangran Qiu et al.
BRAIN (2020)
Using machine learning to quantify structuralMRIneurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases
Karteek Popuri et al.
HUMAN BRAIN MAPPING (2020)
An Ensemble Approach to Predict Schizophrenia Using Protein Data in the N-methyl-D-Aspartate Receptor (NMDAR) and Tryptophan Catabolic Pathways
Eugene Lin et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Biomarkers in the diagnosis and prognosis of Alzheimer's disease
N. Davda et al.
JOURNAL OF NEUROLOGY (2020)
Body Fluid Biomarkers for Alzheimer's Disease-An Up-To-Date Overview
Adrian Florian Balasa et al.
BIOMEDICINES (2020)
Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Sensitivity, Specificity and Potential for Clinical Use
Cristina D'Abramo et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Biomarkers for Alzheimer's Disease Early Diagnosis
Eva Auso et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Deep learning detection of informative features in tau PET for Alzheimer's disease classification
Taeho Jo et al.
BMC BIOINFORMATICS (2020)
The Alzheimer's Disease Clinical Spectrum Diagnosis and Management
Alireza Atri
MEDICAL CLINICS OF NORTH AMERICA (2019)
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
Min Kim et al.
ALZHEIMERS & DEMENTIA (2019)
Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials
Nicola Coley et al.
ALZHEIMERS & DEMENTIA (2019)
Deep Learning in Alzheimer's Disease: Diagnostic Classification and Prognostic Prediction Using Neuroimaging Data
Taeho Jo et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
M/EEG-Based Bio-Markers to Predict the MCI and Alzheimer's Disease: A Review From the ML Perspective
Su Yang et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2019)
D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer's disease or mild cognitive impairment
Chieh-Hsin Lin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
Improving PET Imaging Acquisition and Analysis With Machine Learning: A Narrative Review With Focus on Alzheimer's Disease and Oncology
Ian R. Duffy et al.
MOLECULAR IMAGING (2019)
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort
Daniel Stamate et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Machine Learning Approaches for Clinical Psychology and Psychiatry
Dominic B. Dwyer et al.
Annual Review of Clinical Psychology (2018)
Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging
Hongyoon Choi et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Vijay R. Varma et al.
PLOS MEDICINE (2018)
Development and validation of a novel dementia of Alzheimer's type (DAT) score based on metabolism FDG-PET imaging
Karteek Popuri et al.
NEUROIMAGE-CLINICAL (2018)
Questions concerning the role of amyloid-beta in the definition, aetiology and diagnosis of Alzheimer's disease
Gary P. Morris et al.
ACTA NEUROPATHOLOGICA (2018)
Combination of G72 Genetic Variation and G72 Protein Level to Detect Schizophrenia: Machine Learning Approaches
Eugene Lin et al.
FRONTIERS IN PSYCHIATRY (2018)
Role of Glutamate and NMDA Receptors in Alzheimer's Disease
Rui Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Alzheimer's disease and other dementias: update on research
Lon Schneider
LANCET NEUROLOGY (2017)
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
Sebastian Palmqvist et al.
NATURE COMMUNICATIONS (2017)
Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging
Chieh-Hsin Lin et al.
SCIENTIFIC REPORTS (2017)
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people withmild cognitive impairment (MCI) (Review)
Craig Ritchie et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
An overview on D-amino acids
Giuseppe Genchi
AMINO ACIDS (2017)
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials
Michael W. Weiner et al.
ALZHEIMERS & DEMENTIA (2017)
In Vivo Cortical Spreading Pattern of Tau and Amyloid in the Alzheimer Disease Spectrum
Hanna Cho et al.
ANNALS OF NEUROLOGY (2016)
Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages
Adam J. Schwarz et al.
BRAIN (2016)
Prevalence of Alzheimer Disease in US States
Jennifer Weuve et al.
EPIDEMIOLOGY (2015)
Predicting Prodromal Alzheimer's Disease in Subjects with Mild Cognitive Impairment Using Machine Learning Classification of Multimodal Multicenter Diffusion-Tensor and Magnetic Resonance Imaging Data
Martin Dyrba et al.
JOURNAL OF NEUROIMAGING (2015)
D-serine levels in Alzheimer's disease: implications for novel biomarker development
C. Madeira et al.
TRANSLATIONAL PSYCHIATRY (2015)
Mild to Moderate Alzheimer Dementia with Insufficient Neuropathological Changes
Alberto Serrano-Pozo et al.
ANNALS OF NEUROLOGY (2014)
D-Serine: physiology and pathology
Inna Radzishevsky et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2013)
D-serine increases adult hippocampal neurogenesis
Sebastien Sultan et al.
FRONTIERS IN NEUROSCIENCE (2013)
Brain D-amino acids: a novel class of neuromodulators
Jean-Pierre Mothet et al.
AMINO ACIDS (2012)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Overview of glutamatergic neurotransmission in the nervous system
Mark J. Niciu et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors
Shaomin Li et al.
JOURNAL OF NEUROSCIENCE (2011)
The clinical use of structural MRI in Alzheimer disease
Giovanni B. Frisoni et al.
NATURE REVIEWS NEUROLOGY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
Joseph L. Price et al.
NEUROBIOLOGY OF AGING (2009)
Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake
Shaomin Li et al.
NEURON (2009)
Memory and the NMDA Receptors
Fei Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease
Harald Hampel et al.
ALZHEIMERS & DEMENTIA (2008)
D-amino acids in the brain: D-serine in neurotransmission and neurodegeneration
Herman Wolosker et al.
FEBS JOURNAL (2008)
Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway
Ganesh M. Shankar et al.
JOURNAL OF NEUROSCIENCE (2007)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Pathways towards and away from Alzheimer's disease
MP Mattson
NATURE (2004)
Glutamate and the glutamate receptor system:: a target for drug action
S Bleich et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
分享论文
